| MAC | MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce... |
|---|---|
| QRS | in electrocardiography, the complex consisting of Q, R, and S waves, corresponding to depolarization... |
| SFC | soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| AIMS | abnormal involuntary movement scale; aid for the impaired medical student; arthritis impact measurem... |
| immune adherence | The binding of antigen-antibody complexes or cells coated with antibodies or complement to cells bearing the appropriate complement or Fc receptors. (05 Mar 2000) |
|---|---|
| immune adherence phenomenon | A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex. Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon. (05 Mar 2000) |
| immune adherence reaction | A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound c3 molecules on the c3b receptor sites of the indicator cell. (12 Dec 1998) |
| immune adhesion test | The diagnostic application of the immune adhesion phenomenon. Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test. (05 Mar 2000) |
| immune adsorption | Removal of antibody (agglutinin or precipitin) from antiserum by use of specific antigen; after aggregation has occurred, the antigen-antibody complex is separated either by centrifugation or by filtration, removal of antigen by specific antiserum in a similar manner. (05 Mar 2000) |
| immune agglutination | Agglutination caused by antibody (agglutinin) that is specific for the suspended microorganism, cell, or for an antigen that has been coated on a particle of suitable size. (05 Mar 2000) |
| immune agglutinin | 1. An antibody that causes clumping or agglutination of the bacteria or other cells which either stimulated the formation of the agglutinin, or contain immunologically similar, reactive antigen. Synonym: agglutinating antibody, immune agglutinin. 2. A substance, other than a specific agglutinating antibody, that causes organic particles to agglutinate, commonly qualified, e.g., plant agglutinin. (05 Mar 2000) |
| immune deficiency | Impaired ability of the bodys defence mechanisms to combat infections by bacteria, viruses and fungi. (13 Nov 1997) |
| immune deficiency diseases | Those diseases in which immune reactions are suppressed or reduced. Reasons may include congenital absence of B and/or T lymphocytes or viral killing of helper lymphocytes (see HIV). (18 Nov 1997) |
| immune deviation | Modification of an immune response to an antigen after prior exposure to that antigen. Synonym: split tolerance. (05 Mar 2000) |
| immune electron microscopy | Electron microscopy of biological specimens to which specific antibody has been bound. (05 Mar 2000) |
| immune haemolysin | A sensitizing, complement-fixing, haemolytic antibody formed in an animal as the result of parenteral administration of red blood cells or whole blood from another species; immune haemolysin may also be formed in human beings who are transfused with human blood that is antigenic in the recipient, e.g., the formation of anti-Rh antibody in an Rh-negative person who is treated with Rh-positive red blood cells. (05 Mar 2000) |
| immune haemolysis | Haemolysis caused by complement when erythrocytes have been sensitised by specific complement-fixing antibody. Synonym: conditioned haemolysis. (05 Mar 2000) |
| immune inflammation | See: allergic reaction. (05 Mar 2000) |
| immune interferon | <cytokine> Interferon elaborated by T lymphocytes in response to either specific antigen or mitogenic stimulation. This type II interferon can be produced by recombinant DNA technology and is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity. Synonym: antigen interferon, immune interferon. Pharmacological action: antineoplastic agent, antiviral agents. (20 Sep 2002) |